Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 46 is a pseudogenic copy of the small nuclear RNA 7SK, part of a family of noncoding RNAs involved in regulating RNA polymerase II transcriptional elongation and cellular differentiation pathways[1][2][4]. However, as a pseudogene, RN7SKP46 does not produce a functional RNA product and does not have demonstrated biological activity, molecular interactions, or disease relevance. The functional, canonical, and biologically active form is RN7SK, which regulates transcription by modulating P-TEFb availability, influences cell proliferation, and can impact immune cell polarization and neuronal differentiation[1][2][3][4]. No evidence supports RN7SKP46 as a therapeutic target or as having any functional role in physiology or pathology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 46 (RN7SKP46).